ArticleDocumenta ophthalmologica. Advances in ophthalmology2026
Blue cone monochromacy with parafoveal hyperautofluorescent ring caused by a novel OPN1LW p.Ile109Asn variant.
Article in Documenta ophthalmologica. Advances in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBlue Cone Monochromacy is a rare X-linked retinal disorder characterized by the selective loss of long-(L) and medium-(M) wavelength-sensitive cone function. While typically caused by large-scale genomic deletions or rearrangements within the OPN1LW/OPN1MW gene cluster, missense mutations are less common. Because blue cone monochromacy is often considered a stationary, congenital condition, sporadic cases lacking a family history can often be misidentified. CASE PRESENTATION: A 12-year-old boy presented with reduced visual acuity and a parafoveal hyperautofluorescent ring pattern on fundus autofluorescence and was initially referred for work-up of CRX-related maculopathy. However, electroretinography (ERG) revealed preserved S-cone and rod function with moderately reduced photopic responses. Genetic sequencing identified a novel, maternally inherited, hemizygous missense mutation in the gene encoding OPN1LW (c.326T > A; p.Ile109Asn). AlphaFold simulations demonstrated that the substitution disrupts the 11-cis-retinal binding pocket by altering the hydrogen bonding network near the critical Lys312 residue. This structural instability likely impairs the phototransduction cascade and delays chromophore clearance, contributing to localized foveal photoreceptor stress and the observed macular structural changes.
conclusionsThis report identifies a novel OPN1LW missense variant and provides a mechanistic basis for its pathogenicity through advanced structural modeling. Our findings demonstrate that blue cone monochromacy can present with atypical, progressive-appearing macular features, potentially mimicking Stargardt disease or other maculopathies. Furthermore, this case highlights the utility of in silico protein modeling in bridging the gap between variants and clinical phenotypes, expanding the known molecular spectrum of X-linked cone disorders.
Indexed as
Identifiers
42274835What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.